Olodaterol + tiotropium bromide for the treatment of COPD.

about

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

P2860

Q47159721-01756D05-5E71-4BF4-A880-2DC6B7ACA0B4

P2860

Olodaterol + tiotropium bromide for the treatment of COPD.

Item

http://www.wikidata.org/entity/Q51545895

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Olodaterol + tiotropium bromide for the treatment of COPD.

@en

Olodaterol + tiotropium bromide for the treatment of COPD.

@nl

type

Item

label

Olodaterol + tiotropium bromide for the treatment of COPD.

@en

Olodaterol + tiotropium bromide for the treatment of COPD.

@nl

prefLabel

Olodaterol + tiotropium bromide for the treatment of COPD.

@en

Olodaterol + tiotropium bromide for the treatment of COPD.

@nl

P1476

Olodaterol + tiotropium bromide for the treatment of COPD

@en

P2093

Chiara Ciaprini

http://www.w3.org/2001/XMLSchema#string

Mario Cazzola

http://www.w3.org/2001/XMLSchema#string

P2860

Ten years of tiotropium: clinical impact and patient perspectives

Clinical and economic impact of non-adherence in COPD: a systematic review

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

Efficacy and safety of combining olodaterol Respimat(®) and tiotropium HandiHaler(®) in patients with COPD: results of two randomized, double-blind, active-controlled studies.

Bronchodilator reversibility testing in chronic obstructive pulmonary disease

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).

Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis.

Randomized, Double-Blind, Dose-Finding Study for Tiotropium when Added to Olodaterol, Administered via the Respimat® Inhaler in Patients with Chronic Obstructive Pulmonary Disease.

P304

379-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17476348.2016.1156538

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luigino Calzetta

Ermanno Puxeddu

P577

2016-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26894830

http://www.w3.org/2001/XMLSchema#string

Olodaterol + tiotropium bromide for the treatment of COPD.

about

P2860

P2860

Olodaterol + tiotropium bromide for the treatment of COPD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698